Premium
Treatment delays for muscle‐invasive bladder cancer
Author(s) -
Masic Selma,
Smaldone Marc C.
Publication year - 2019
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.32047
Subject(s) - medicine , bladder cancer , socioeconomic status , empowerment , cancer , intensive care medicine , patient empowerment , environmental health , population , economic growth , economics
Growing evidence supports the importance of timely care for muscle‐invasive bladder cancer, with multiple studies demonstrating that delays longer than 3 months are associated with worse outcomes. Causes for treatment delays are multifactorial and may be compounded by increasing regionalization; contemporary efforts to minimize delays must address cross‐team communication, care transitions, patient empowerment, socioeconomic differences, and access disparities.